Effect of Compression on Interaction between 1,4-Dihydropyridine Compounds and Lactose Monohydrate
スポンサーリンク
概要
- 論文の詳細を見る
Manidipine dihydrochloride or benidipine hydrochloride will change to hydrate form in part, when differential scanning calorimetric (DSC) measurement is carried out together with lactose monohydrate. This interaction was accelerated by compressing their mixture. It can be suggested that the interaction may cause by the disruption of crystal structure of lactose monohydrate due to compression to set free of water molecules. A new DSC peak at 170℃, which was not observed in each component, appeared in DSC measurement of a mixture. This will be based on hydrate formed by the interaction, i.e., movement of water molecules. The profile of the plotting of the DSC peak area ratio before and after compression against the compression force changed by the molar ratio of lactose monohydrate in a mixture. In the case of low molar ratio of lactose monohydrate, profiles for manidipine dihydrochloride and benidipine hydrochloride differed from each other. This will be because manidipine dihydrochloride is stickier than benidipine hydrochloride. The profile for manidipine dihydrochloride became more gradual and showed lag compression force region when the amount of addition of the lubricant, magnesium stearate in a mixture increased. The endothermic peak area at 170℃ for manidipine dihydrochloride was larger than that for benidipine hydrochloride. It should be suggested that benidipine hydrochloride is easier to be transformed to its hydrate than manidipine dihydrochloride.
- 公益社団法人日本薬学会の論文
- 2005-05-01
著者
-
Sato Mika
Research And Development Division Sawai Pharmaceutical Co. Ltd.
-
HOSAKA Shouichi
Research and Development Division, Sawai Pharmaceutical Co., Ltd.
-
HAMADA Chikayuki
Research and Development Division, Sawai Pharmaceutical Co., Ltd.
-
TAKAHASHI Yoshiteru
Research and Development Division, Sawai Pharmaceutical Co., Ltd.
-
KITAMORI Nobuyuki
Research and Development Division, Sawai Pharmaceutical Co., Ltd.
-
OZAWA Yoshiki
Research and Development Division, Sawai Pharmaceutical Co., Ltd.
-
Hosaka Shouichi
Research And Development Division Sawai Pharmaceutical Co. Ltd.
-
Hamada Chikayuki
Research And Development Division Sawai Pharmaceutical Co. Ltd.
-
Kitamori Nobuyuki
Research And Development Division Sawai Pharmaceutical Co. Ltd.
-
Takahashi Yoshiteru
Research And Development Division Sawai Pharmaceutical Co. Ltd.
-
Ozawa Yoshiki
Research And Development Division Sawai Pharmaceutical Co. Ltd.
関連論文
- Effects of Compression on the Interaction between 1,4-Dihydropyridine Compounds and Lactose Monohydrate (II): Differences in Powder Properties of 1,4-Dihydropyridine Compounds
- Effect of Compression on Interaction between 1,4-Dihydropyridine Compounds and Lactose Monohydrate